ACS Central Science (Jun 2019)
Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT‑1 Controlled Pathways
- Carolin M.-L. Gleissner,
- Carolin L. Pyka,
- Wolfgang Heydenreuter,
- Thomas F. Gronauer,
- Carina Atzberger,
- Vadim S. Korotkov,
- Weiting Cheng,
- Stephan M. Hacker,
- Angelika M. Vollmar,
- Simone Braig,
- Stephan A. Sieber
Affiliations
- Carolin M.-L. Gleissner
- Center for Integrated Protein Science at the Department of Chemistry, Technische Universität München, Garching, Germany
- Carolin L. Pyka
- Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich (LMU), Munich, Germany
- Wolfgang Heydenreuter
- Center for Integrated Protein Science at the Department of Chemistry, Technische Universität München, Garching, Germany
- Thomas F. Gronauer
- Center for Integrated Protein Science at the Department of Chemistry, Technische Universität München, Garching, Germany
- Carina Atzberger
- Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich (LMU), Munich, Germany
- Vadim S. Korotkov
- Center for Integrated Protein Science at the Department of Chemistry, Technische Universität München, Garching, Germany
- Weiting Cheng
- Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich (LMU), Munich, Germany
- Stephan M. Hacker
- Department of Chemistry, Technische Universität München, Garching, Germany
- Angelika M. Vollmar
- Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich (LMU), Munich, Germany
- Simone Braig
- Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich (LMU), Munich, Germany
- Stephan A. Sieber
- Center for Integrated Protein Science at the Department of Chemistry, Technische Universität München, Garching, Germany
- DOI
- https://doi.org/10.1021/acscentsci.9b00266
- Journal volume & issue
-
Vol. 5,
no. 7
pp. 1170 – 1178
Abstract
No abstracts available.
